We are developing a groundbreaking new drug that’s going to revolutionize the treatment of aggressive cancers.
Starting from an original concept of re-purposing an established anti-alcoholism drug, we are presently taking our proprietary formulation of PLGA encapsulated disulfiram through pre-clinical studies for approval to enter clinical trial.
Company Details
- Employees
- 2
- Founded
- 2018
- Address
- Science Centre, University Of Wolverhampton Science Park, Wolverhampton,wv10 9ru,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- spinning-composites.com
- Keywords
- Oncology, Disulfiram, Drug Development, Pre-clinical, Cytotoxicity testing, Mechanism or Action Studies, Drug Encapulsation, Formulation testing.
- HQ
- Wolverhampton
Disulfican Ltd Questions
Disulfican Ltd's website is spinning-composites.com
Disulfican Ltd's LinkedIn profile is https://uk.linkedin.com/company/disulfican-ltd
Disulfican Ltd has
2 employees.
View email and phone details for 2
employees at Disulfican Ltd.
Disulfican Ltd's industry is
Pharmaceutical Manufacturing
Disulfican Ltd's top competitors are
Brook Street,
Hummingbird Bioscience,
Kargenera (Currently In Stealth Mode),
Biograd,
Dyson,
Acrivon Therapeutics, Inc.,
Alimentiv,
Dark Matter Tx Inc.,
Ghp Scientific,
Eurofins Pss Insourcing Solutions.
Disulfican Ltd's categories are Pharmaceutical Manufacturing
Disulfican Ltd's founding year is 2018
